Clinical Trial ES 900 - 2016

Clinical Trial ES 900 - 2016

The primary objective of this clinical trial is to assess the clinical performance of the investigational device. To that end, for each measure and the in-vivo repeatability will be quantified, as well as the mean measurement deviation with respect to the current gold standard device. As a secondary objective of the study, raw measurement data will be collected, to allow for improvements of existing algorithms, development of additional measure and and for retrospective analysis.

EYESTAR 900 (the investigational device) is a new device by HAAG-STREIT AG, for measurement of optical biometry and advanced corneal topography by swept-source optical coherence tomography (OCT).

Inclusion Criteria:

• 18 years or older;
• volunteers with phakic eyes, no cataract surgery indicated and with existing vitreous;
• patients seeking cataract surgery;
• patients with pseudophakic eye;
• patients with oil-filled eye;
• patients with aphakic eye.

Exclusion Criteria:

• underage patients (younger than 18 years);
• vulnerable patients;
• inability to give informed consent;
• inability to maintain stable fixation.